美年健康(002044.SZ)吹響集結號 300醫護精鋭包機增援湖北抗疫一線
來源：格隆匯
2月13日，美年大健康產業控股股份有限公司(以下簡稱“美年大健康”)吹響抗疫集結號，以緊急動員令的形式，面向全國美年、慈銘、奧亞、美兆團隊，徵召300名精鋭醫護人員，計劃2月20日起，分兩批包機增援武漢抗疫一線。
目前，全國的疫情防控已進入全面總攻階段，湖北及武漢的疫情形勢依然嚴峻，重點醫療機構的醫護人員依然短缺。在此背景下，美年大健康強調“疫情就是命令，防控就是責任”，一紙緊急動員令，短短4小時，全集團報名人數即達700人，至報名截止，共有2672名醫護人員請願出征，平均每10個美年大健康的醫護人員中就有1人報名。
為保障即將奔赴一線的300名醫護人員的防護安全，美年大健康將舉行兩次專業培訓，同時從日本、新西蘭空運一批保障物資作為後勤支持。吉祥航空將免費提供最新型787飛機，確保首批醫務人員第一時間抵達湖北抗疫前線。
作為中國最大的預防醫學龍頭企業，美年大健康號召全員以堅定信心打響抗疫攻堅戰，以過硬舉措和專業行動，支援一線科學防疫，切實履行守護國人健康的責任擔當。疫情爆發至今，已有醫護人員共計1427名志願者，放棄春節休假，紛紛走上高速路口、火車站、機場、客運站等交通關口，承擔起全國503個體温防控點監測工作。
此次，除300醫護人員赴湖北一線增援外，美年大健康還將聯合大象醫生彙集全國影像專家，通過互聯網遠程診斷，在政府統一部署下，投身患者醫療救治工作，緩解一線壓力。
鏈接：美年大健康抗疫舉措
1月27日-2月1日，美年大健康聯手碩世生物，向湖北省16個縣市30餘家醫院，共捐贈9.06萬人份，總價值1800萬元的新冠肺炎試劑及儀器，為緩解湖北疫區“確診難”問題雪中送炭。
1月28日至今，美年大健康聯合大象醫生、優健康、萬里雲、綠葉醫療、人民日報健康及健康時報，推出“抗擊新冠，為健康護航”線上愛心義診諮詢、遠程閲片、心理援助等服務，共有1207位美年醫生參與相關服務。
2月8日美年健康在阿里健康平台發起線上義診服務，來自美年健康的10名專家醫生，每天8:30-17:30為用户提供在線諮詢服務全國5家省級上線阿里健康，首日義診超300餘人次。
2月10日，美年大健康集團推出返崗復工防疫篩查預約服務，面向無症狀且無密切接觸史，但需要集中辦公或廣泛接觸人流的人羣，開放全國體檢門診CT，提供肺部CT的篩查確診服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
